Literature DB >> 19321879

The role of negatively charged lipids in lysosomal phospholipase A2 function.

Akira Abe1, James A Shayman.   

Abstract

Lysosomal phospholipase A2 (LPLA2) is characterized by increased activity toward zwitterionic phospholipid liposomes containing negatively charged lipids under acidic conditions. The effect of anionic lipids on LPLA2 activity was investigated. Mouse LPLA2 activity was assayed as C2-ceramide transacylation. Sulfatide incorporated into liposomes enhanced LPLA2 activity under acidic conditions and was weakened by NaCl or increased pH. Amiodarone, a cationic amphiphilic drug, reduced LPLA2 activity. LPLA2 exhibited esterase activity when p-nitro-phenylbutyrate (pNPB) was used as a substrate. Unlike the phospholipase A2 activity, the esterase activity was detected over wide pH range and not inhibited by NaCl or amiodarone. Presteady-state kinetics using pNPB were consistent with the formation of an acyl-enzyme intermediate. C2-ceramide was an acceptor for the acyl group of the acyl-enzyme but was not available as the acyl group acceptor when dispersed in liposomes containing amiodarone. Cosedimentation of LPLA2 with liposomes was enhanced in the presence of sulfatide and was reduced by raising NaCl, amiodarone, or pH in the reaction mixture. LPLA2 adsorption to negatively charged lipid membrane surfaces through an electrostatic attraction, therefore, enhances LPLA2 enzyme activity toward insoluble substrates. Thus, anionic lipids present within lipid membranes enhance the rate of phospholipid hydrolysis by LPLA2 at lipid-water interfaces.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321879      PMCID: PMC2739751          DOI: 10.1194/jlr.M900008-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

Review 1.  Anionic phospholipids, interfacial binding and the regulation of cell functions.

Authors:  A G Buckland; D C Wilton
Journal:  Biochim Biophys Acta       Date:  2000-01-17

Review 2.  Drug-induced phospholipidosis: are there functional consequences?

Authors:  M J Reasor; S Kacew
Journal:  Exp Biol Med (Maywood)       Date:  2001-10

Review 3.  A role for lysosomal phospholipase A2 in drug induced phospholipidosis.

Authors:  Akira Abe; Miki Hiraoka; James A Shayman
Journal:  Drug Metab Lett       Date:  2007-01

4.  Ca2+-induced fusion of sulfatide-containing phosphatidylethanolamine small unilamellar vesicles.

Authors:  X Wu; Q T Li
Journal:  J Lipid Res       Date:  1999-07       Impact factor: 5.922

5.  Lysosomal phospholipase A2 and phospholipidosis.

Authors:  Miki Hiraoka; Akira Abe; Ye Lu; Kui Yang; Xianlin Han; Richard W Gross; James A Shayman
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 6.  Sphingolipid metabolism diseases.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Biochim Biophys Acta       Date:  2006-06-14

7.  Modulation of the in vitro activity of lysosomal phospholipase A1 by membrane lipids.

Authors:  Jocelyne Piret; André Schanck; Sylvie Delfosse; Françoise Van Bambeke; Bellamkonda K Kishore; Paul M Tulkens; Marie-Paule Mingeot-Leclercq
Journal:  Chem Phys Lipids       Date:  2005-01       Impact factor: 3.329

8.  Structure and function of lysosomal phospholipase A2: identification of the catalytic triad and the role of cysteine residues.

Authors:  Miki Hiraoka; Akira Abe; James A Shayman
Journal:  J Lipid Res       Date:  2005-08-16       Impact factor: 5.922

9.  The secretion and uptake of lysosomal phospholipase A2 by alveolar macrophages.

Authors:  Akira Abe; Robert Kelly; Jessica Kollmeyer; Miki Hiraoka; Ye Lu; James A Shayman
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  The acylation of lipophilic alcohols by lysosomal phospholipase A2.

Authors:  Akira Abe; Miki Hiraoka; James A Shayman
Journal:  J Lipid Res       Date:  2007-07-12       Impact factor: 5.922

View more
  22 in total

Review 1.  Group XV phospholipase A₂, a lysosomal phospholipase A₂.

Authors:  James A Shayman; Robert Kelly; Jessica Kollmeyer; Yongqun He; Akira Abe
Journal:  Prog Lipid Res       Date:  2010-11-11       Impact factor: 16.195

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Preferential hydrolysis of truncated oxidized glycerophospholipids by lysosomal phospholipase A2.

Authors:  Akira Abe; Miki Hiraoka; Hiroshi Ohguro; John J Tesmer; James A Shayman
Journal:  J Lipid Res       Date:  2016-12-19       Impact factor: 5.922

4.  A fluorogenic phospholipid for the detection of lysosomal phospholipase A2 activity.

Authors:  Akira Abe; Piotr W Rzepecki; James A Shayman
Journal:  Anal Biochem       Date:  2012-11-09       Impact factor: 3.365

5.  The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power.

Authors:  Melissa K Passarelli; Alexander Pirkl; Rudolf Moellers; Dmitry Grinfeld; Felix Kollmer; Rasmus Havelund; Carla F Newman; Peter S Marshall; Henrik Arlinghaus; Morgan R Alexander; Andy West; Stevan Horning; Ewald Niehuis; Alexander Makarov; Colin T Dollery; Ian S Gilmore
Journal:  Nat Methods       Date:  2017-11-13       Impact factor: 28.547

Review 6.  Biological function of the cellular lipid BMP-BMP as a key activator for cholesterol sorting and membrane digestion.

Authors:  Hichem D Gallala; Konrad Sandhoff
Journal:  Neurochem Res       Date:  2010-12-07       Impact factor: 3.996

7.  Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.

Authors:  Susi Anheuser; Bernadette Breiden; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2019-04-15       Impact factor: 5.922

8.  Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase.

Authors:  Misbaudeen Abdul-Hammed; Bernadette Breiden; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2017-01-26       Impact factor: 5.922

Review 9.  Lysosomal phospholipase A2.

Authors:  James A Shayman; John J G Tesmer
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-02       Impact factor: 4.698

Review 10.  Drug induced phospholipidosis: an acquired lysosomal storage disorder.

Authors:  James A Shayman; Akira Abe
Journal:  Biochim Biophys Acta       Date:  2012-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.